- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04251143
Dresden Corneal Disease and Treatment Study
Dresden Corneal Disease and Treatment Study - Analysis for Quality Inspection of Follow-up and Treatment Procedures of Corneal Diseases of the Department of Ophthalmology (University Hospital Carl Gustav Carus Dresden)
Study Overview
Status
Intervention / Treatment
Detailed Description
Corneal ectasia (e.g. keratoconus) is a corneal disease that is characterized by irregular steepening of corneal curvature, stromal thinning and reduced biomechanical properties. As a result of this, visual acuity is reduced and can improved by spectacles in early state or with rigid gas permeable contact lenses in mild as well as advanced stage of the disease. Furthermore, in moderate and advanced cases stromal scarring occurs that affected the vision negatively. Therefore, a corneal transplantation is needed. Since the introduction of corneal cross-linking, the amount of corneal transplantations has been reduced. It is necessary to perform closely examinations to detect the progression of the disease as well as post-operatively follow-ups to confirm treatment success.
Parameters being analyzed are:
Age, sex, refraction, family history, known duration of ectasia, previous ocular surgery, systemic diseases, systemic and topical medication;
biomicroscopy, anterior optical coherence tomography (OCT), Scheimpflug-based tomography (Pentacam), Biomechanical assessment (Ocular Response Analyzer and Corneal Visualization with the Scheimpflug Technology), optical biometry, confocal microscopy, endothelium cell count.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Saxony
-
Dresden, Saxony, Germany, 01307
- Recruiting
- Department of Ophthalmology; Medical Faculty Carl Gustav Carus; Technical University Dresden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- corneal disease
- corneal ectasia
Exclusion Criteria:
- pregnancy
- age under 18 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Ectasia
Keratoconus, Keratoconus suspects
|
UV-A Irradiation and riboflavin
Detailed Information about corneal tomography is used for diagnosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Follow-up intervals
Time Frame: 15 years
|
To find the best follow-up intervals for keratoconus patients with or without progression of the disease
|
15 years
|
postoperative follow-up intervals
Time Frame: 15 years
|
To find the best follow-up intervals for keratoconus patients after surgical Intervention.
|
15 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of treatment quality
Time Frame: 15 years
|
What is the best treatment option for the individual patient?
|
15 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Herber R, Lenk J, Pillunat LE, Raiskup F. Comparison of corneal tomography using a novel swept-source optical coherence tomographer and rotating Scheimpflug system in normal and keratoconus eyes: repeatability and agreement analysis. Eye Vis (Lond). 2022 May 23;9(1):19. doi: 10.1186/s40662-022-00290-6.
- Herber R, Pillunat LE, Raiskup F. Development of a classification system based on corneal biomechanical properties using artificial intelligence predicting keratoconus severity. Eye Vis (Lond). 2021 Jun 1;8(1):21. doi: 10.1186/s40662-021-00244-4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK 104032018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Astigmatism
-
Cairo UniversityUnknown
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
-
Bausch & Lomb IncorporatedCompleted
-
University Clinic FrankfurtCompleted
-
London Vision ClinicOptana GmbHRecruitingCorneal AstigmatismUnited Kingdom
-
Wenzhou Medical UniversityCompletedCorneal Astigmatism | OrientationChina
-
Cornea and Laser Eye InstituteRecruitingKeratoconus | Corneal Ectasia | Irregular Astigmatism | Aberration, Corneal Wavefront | Wavefront Aberration, Corneal | Pellucid Marginal Corneal Degeneration | KeratoglobusUnited States
-
Alcon ResearchNot yet recruiting
-
Sohag UniversityNot yet recruiting
-
Wenzhou Medical UniversityNot yet recruitingCataract | Corneal Astigmatism
Clinical Trials on corneal cross-linking
-
Medical University of ViennaTerminatedKeratoconus | Pellucid Marginal DegenerationAustria
-
Instituto de Oftalmología Fundación Conde de ValencianaRecruiting
-
Democritus University of ThraceCompleted
-
University of PlymouthUnknown
-
Luca BuzzonettiCompleted
-
Shahid Beheshti UniversityTehran University of Medical Sciences; Negah Eye CenterActive, not recruitingKeratoconus | Corneal Cross-LinkingIran, Islamic Republic of
-
University Hospital, MontpellierRecruiting
-
Bruce AllanMoorfields Eye Hospital NHS Foundation TrustCompleted
-
Minia UniversityRecruiting